Basic Information
Basic information for LINC00343-220-12aa
Peptide Name LINC00343-220-12aa
Genome Position chr13:105707723-105707758[+]
Species Human
Peptide Sequence MVKYFHYLACLL
Peptide Length 12
Unique No (LINC00343-203-12aa,LINC00343-217-12aa,LINC00343-222-12aa,LINC00343-226-12aa,LINC00343-233-12aa,LINC00343-242-12aa,LINC00343-259-12aa,LINC00343-268-12aa,LINC00343-271-12aa,LINC00343-276-12aa,LINC00343-277-12aa,LINC00343-280-12aa,LINC00343-283-12aa,LINC00343-285-12aa,LINC00343-298-12aa,LINC00343-305-12aa,LINC00343-330-12aa)
Grand Average of Hydropathicity 1.2417
Relative Molecular Mass 1699.04
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000654904;LINC00343-220
Transcript Length 1308
Coding Ability 0.5642
DNA Sequence Corresponding to Peptide ATGGTGAAGTATTTTCACTATTTGGCATGTCTTCTC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :